Author

Merete Lorentzen 1

1 Oslo University Hospital, Rikshospitalet, Department of Dermatology, Oslo, Norway

BIOSIMILAR INFLIXIMAB (CT-P13) IS NOT INFERIOR TO ORIGINATOR INFLIXIMAB: RESULTS FROM THE 52-WEEK RANDOMIZED NOR-SWITCH TRIAL

Kristin K Jørgensen, Inge C Olsen, Guro L Goll, Merete Lorentzen, Nils Bolstad, Espen A Haavardsholm, Knut E.A. Lundin, Cato Mørk, Jørgen Jahnsen, Tore K Kvien

Item 1 - 1 / 1
1